Huntington National Bank »

Inhibrx Biosciences shares owned by Huntington National Bank

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Huntington National Bank from 13F filings

Historical chart of Huntington National Bank investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Huntington National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Huntington National Bank

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.4k 90 15.40
2024-09-30 $1.4k 90 15.66

More positions owned by Huntington National Bank

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Jp Morgan Chase & Co Common Stock (JPM)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
Vanguard Exchange Traded (Principal) (VEA)
Ishares Exchange Traded (Principal) (IVV)
Broadcom Common Stock (AVGO)
Amazon.com Common Stock (AMZN)
Ishares Exchange Traded (Principal) (IJH)
Meta Platforms Common Stock (META)
Netflix Common Stock (NFLX)
Ishares Exchange Traded (Principal) (IJR)
Exxon Mobil Corp Common Stock (XOM)
Eli Lilly & Co Common Stock (LLY)

View all positions for Huntington National Bank

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
Sanofi
HighTower Advisors
BlackRock
Vanguard Group
Sofinnova Ventures
Woodline Partners
Millennium Management
Partner Fund Management
Caligan Partners
Geode Capital Management
State Street Corporation
Readystate Asset Management
Kennedy Capital Management

View all funds holding Inhibrx Biosciences